MarketingRx roundup: Astellas menopause drug led NFL TV spending; A podcast's deep dive into Novo's history
Astellas introduces menopause drug to NFL audience: Astellas spent more money advertising its menopause drug Veozah than any other new brand on regular NFL broadcasts in the 2023-2024 season so far, according to data from real-time TV ad tracker iSpot.tv. It spent $24.1 million from September through the first week of January, with ESPN, BET, AT&T, The Farmer’s Dog and Chili’s rounding out the top new advertisers this season. Pfizer’s Nurtec and AstraZeneca’s Breztri Aerosphere also made the top 10 new brands list at nos. 7 and 8, respectively.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.